GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (WBO:GXI) » Definitions » 5-Year ROIIC %

Gerresheimer AG (WBO:GXI) 5-Year ROIIC % : -17.21% (As of Nov. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Gerresheimer AG 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Gerresheimer AG's 5-Year ROIIC % for the quarter that ended in Nov. 2023 was -17.21%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Gerresheimer AG's 5-Year ROIIC % or its related term are showing as below:

WBO:GXI's 5-Year ROIIC % is ranked worse than
65.9% of 780 companies
in the Medical Devices & Instruments industry
Industry Median: -0.035 vs WBO:GXI: -17.21

Gerresheimer AG 5-Year ROIIC % Historical Data

The historical data trend for Gerresheimer AG's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG 5-Year ROIIC % Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.09 30.54 -0.18 1.22 -17.21

Gerresheimer AG Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -17.21 - - -

Competitive Comparison of Gerresheimer AG's 5-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's 5-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's 5-Year ROIIC % falls into.



Gerresheimer AG 5-Year ROIIC % Calculation

Gerresheimer AG's 5-Year ROIIC % for the quarter that ended in Nov. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 164.568712 (Nov. 2023) - 235.0183088 (Nov. 2018) )/( 3114.892 (Nov. 2023) - 2705.575 (Nov. 2018) )
=-70.4495968/409.317
=-17.21%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Gerresheimer AG  (WBO:GXI) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Gerresheimer AG 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG Business Description

Traded in Other Exchanges
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG Headlines

No Headlines